France-based NovAliX has entered into a fragment-based drug discovery project with Japanese biopharmaceutical firm Kyowa Hakko Kirin. The deal, which is a continuation of the alliance announced in January 2013, builds upon the positive ...
Ensemble Therapeutics has entered into two-part research and development collaboration with Novartis for oral, macrocyclic inflammatory cytokine IL-17 antagonists and additional disease targets. The collaboration will leverage Ensemble's ...
Tags: Ensemble Therapeutics, Novartis
Proteros biostructures has collaborated with Priaxon to develop lead compounds for high value protein-protein interaction (PPI) drug targets. The combination of Proteros' structure guided discovery with Priaxon's PPI-directed drug ...
Tags: Proteros, Priaxon Collaborate, PPI Drug
Vernalis has reached a research milestone as part of the oncology drug discovery alliance with French pharmaceutical company, Servier. Under the drug discovery program, Vernalis will receive a payment of €0.5m from Servier on ...
Tags: drug discovery platforms, oncology drug discovery, undisclosed oncology